 |
dupilumab |
|---|---|
| Trade Name | |
| Orphan Indication | Eosinophilic esophagitis Eosinophilic esophagitis |
| USA Market Approval | USA |
| USA Designation Date | 2017-09-05 00:00:00 |
| Sponsor | Regneron Pharmaceuticals, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591 |
Learn more about: